What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

We spoke to Allison Watson (Ring20 Research & Support UK CIO) about her journey following her son’s diagnosis of a rare form ...

Lyndsey: Hi everybody, and welcome back to FoGCast. Manny and myself are diving into the future of healthcare with a true pioneer. Anu Acharya is described as a serial entrepreneur and is the ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

As advancements in genetic technologies accelerate at an astonishing pace, the potential for gene editing to transform our world becomes closer to being realised. With the advent of revolutionary ...

How will multi-omics change healthcare? With new ways to integrate data, new applications in precision medicine, and the emerging potential of AI and machine learning for analysis, it is an exciting ...

Is science in the throes of a “reproducibility crisis”? If someone followed the same methods, techniques, and reagents as your experiment, would they have the same results? This describes the core ...

Single-cell transcriptomics, or scRNA-seq, is widely used for analysing the transcriptome of single-cell populations. With scRNA-seq, gene expression profiling can explore genotype-phenotype ...

Written by Arpita Kulkarni (Director of the Functional Genomics and Bioinformatics Core at HMS/BIDMC). Across the life sciences, a quiet anxiety is growing: what is the role of the experimental ...

“Strange is this little animal, because of its exceptional and strange morphology and because it closely resembles a bear en miniature. That is the reason why I decided to call it little water bear.” ...

Illumina’s systems employ short-read sequencing techniques, which has been the predominant NGS technology for the last decade. The company has made huge advances in the NGS space and now markets a ...

As technology advances, we’re used to hearing about the latest in a seemingly never-ending list of ‘omics’. With each one hailed as more promising than the last, opportunities in the life sciences ...